BCAB BioAtla, Inc.
Healthcare$3.91+5.96%ClosedMarket Cap: $4.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.16
P/S
2.47
EV/EBITDA
-0.19
DCF Value
$-4.98
FCF Yield
-467.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
106.0%
Operating Margin
-2525.0%
Net Margin
-2530.8%
ROE
166.7%
ROA
-590.9%
ROIC
477.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-8.8M | $-6.3M | $— | — |
| Q4 null | $2.0M | 140.3% | $-9.3M | $-9.8M | $— | — |
| FY null | $2.0M | 100.0% | $-59.3M | $-59.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-13.8M | $-15.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-18.6M | $-18.7M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-17.6M | $-15.3M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-16.2M | $-14.9M | $— | — |
| FY null | $11.0M | 91.6% | $-73.9M | $-69.8M | $— | — |
| Q3 null | $11.0M | 97.9% | $-11.3M | $-10.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-22.0M | $-21.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-24.5M | $-23.2M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-28.5M | $-26.9M | $-28.00 | — |